Curemark
Focus: Curemark is a biotechnology company specializing in enzyme treatment therapies, headquartered in Rye Brook, NY. The company focuses on developing novel therapeutic approaches through enzyme-based interventions.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Curemark
AI assessmentNot HiringNo open roles listed right now. Follow Curemark to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CM-AT
AutismClinical Trials (1)
NCT00912691A Trial of CM-AT in Children With Autism- Open Label Extension Study
Phase 3Help build intelligence for Curemark
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.